Arkis BioSciences Inc. — Form D
Arkis BioSciences Inc. of KNOXVILLE, TN, a company, filed a Form D exempt-offering notice with the SEC on 2018-08-29. The offering totals $4.5M, of which $4.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-08-29
- Form: D
- Accession: 0001679188-18-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.5M
- Amount sold: $4.5M
- Investors: 25
- Date of first sale: 2018-01-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-320303
Issuer
- Name: Arkis BioSciences Inc.
- CIK: 0001679188
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 2704 CHEROKEE FARM WAY, KNOXVILLE, TN, 37920
- Phone: 844-247-5383
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| James A Killeffer, M.D. | Director | Knoxville, TN |
| Clif A Moyers | Director | Knoxville, TN |
| Chad E Seaver | Director | Knoxville, TN |
| Ken A Woody | Director | Knoxville, TN |
| Stephen A Arnold | Executive Officer | Knoxville, TN |
| Quentin A Aten | Executive Officer | Knoxville, TN |
| James A Killeffer, M.D. | Executive Officer | Knoxville, TN |
| Chad E Seaver | Executive Officer | Knoxville, TN |
Other filings by this issuer (2)
More